Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huashen Pharmaceutical is a private pharmaceutical company based in Beijing, China, founded in 1995. The company specializes primarily in herbal medicines and has at least one approved product—Yifei Qinghua granule—for lung diseases. This product received approval for use in China on November 17, 2020. There are no indications that the company operates as a platform technology provider or that it has been acquired by another entity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Huashen Pharmaceutical.